The latest research study “Liver Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global liver disease treatment market size reached a value of US$ 20.83 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 30.91 Billion by 2027 exhibiting a CAGR of 6.50% during 2022-2027.
Liver is a vital body organ that carries out essential functions, such as storing vitamins and nutrients, clearing toxic compounds from the blood, and maintaining a proper balance of chemicals in the body. Some common liver diseases include cancer, autoimmune diseases, hepatitis, and genetic disorders. The major causes of these diseases are infections, genetics, obesity, diabetes, and immune system abnormalities. They can be treated using various therapeutic techniques for liver diseases, including immunosuppressants, immunoglobulins, corticosteroids, chemotherapy, vaccinations, and antiviral medications. Since liver disease treatment helps optimize liver functioning, protect liver cells from inflammation, detoxify, improve metabolism, and increase enzyme and bile production, it is gaining immense traction across the globe.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/liver-disease-treatment-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Liver Disease Treatment Market Trends and Drivers:
The global liver disease treatment market is primarily driven by the rising geriatric population that is more susceptible to developing chronic liver diseases. Moreover, the growing prevalence of fatty liver disease due to diabetes, hypertension (high blood pressure), obesity, and high cholesterol has augmented the product demand.
Additionally, numerous technological advancements, such as the development of the bioartificial liver, are contributing to market growth. Besides this, the surging adoption of safe and effective antiviral medications that help suppress the hepatitis B virus, and lower the risk of developing cirrhosis and hepatocellular carcinoma, is positively influencing the market growth.
Furthermore, several favorable initiatives undertaken by governments of numerous countries to promote public health is catalyzing the market growth. Other factors, including ongoing research and development (R&D) activities, rapid growth in the healthcare industry, changing dietary patterns, and sedentary lifestyles, are also anticipated to create a positive market outlook.
Global Liver Disease Treatment Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Liver Disease Treatment Companies:
Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Viatris Inc.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5023&flag=C
The report has segmented the market on the basis of region, treatment type, disease type and end user.
Breakup by Treatment Type:
- Antiviral Drugs
- Immunosuppressants
- Vaccines
- Immunoglobulins
- Corticosteroids
- Targeted Therapy
- Chemotherapy
Breakup by Disease Type:
- Hepatitis
- Autoimmune Diseases
- Non-alcoholic Fatty Liver Disease (NAFLD)
- Cancer
- Genetic Disorders
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
